Regulation (EU) 2022/123 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices is on the Healthcare & Medical Devices rulebook because its official title matches medical device. Source: EUR-Lex and European Parliament procedure file; company-specific applicability still depends on your activities. Methodology

Regulation (EU) 2022/123 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices: what it means for Healthcare & Medical Devices

The Regulation (EU) 2022/123 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices is part of the EU rulebook for healthcare & medical devices. Its subject matter covers medical devicecore to the sector. Here’s what the act does, why it’s on your radar, and how to see whether it affects your specific company.

Act
32022R0123
Type
Regulation
Stage
Procedure completed
Dated
2022-01-25
Procedure
2020/0321(COD)
Lead committee
ENVI

What the act does

to reinforce the role of the European Medicines Agency (EMA) in crisis preparedness and management for medicinal products and medical devices. PROPOSED ACT: Regulation of the European Parliament and of the Council. ROLE OF THE EUROPEAN PARLIAMENT: the European Parliament decides in accordance with the ordinary legislative procedure and on an equal footing with the Council. BACKGROUND: the unprecedented experience of the COVID-19 pandemic has demonstrated that the EU’s ability to coordinate work to ensure the availability of medicinal products and medical devices and facilitate their development is currently…

Read the full Regulation (EU) 2022/123 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices explainer →

Why it matters for Healthcare & Medical Devices

Healthcare, medtech and digital-health companies face EU rules on medical devices, diagnostics and health data. These are the EU acts most likely to apply.

Regulation (EU) 2022/123 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices sits in that rulebook because its subject matter covers medical device. Whether — and how — it applies to a given business depends on that business’s activities, products and markets.

Does the Regulation (EU) 2022/123 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices apply to your company?

This act’s scope covers:

  • medical device

Does your business touch any of these?

The rest of the Healthcare & Medical Devices rulebook

See all EU regulation for Healthcare & Medical Devices

Monitor this regulation

Get an email when Regulation (EU) 2022/123 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices advances — free, no account. We only email on real changes.

Primary sources

The act’s summary is the European Parliament’s own procedure record; the sector connection is the act’s stated subject matter. Lex shows the law and the grounded connection — not legal advice. Data © European Union (Decision 2011/833/EU). Methodology.